{"id":"oral-capsule-faecal-microbiota-transplantation","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Abdominal pain"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This process aims to treat various conditions by introducing beneficial microbes that can help to crowd out pathogenic bacteria, promoting a balanced gut microbiome. The exact mechanisms of action are not fully understood, but it is thought to involve the modulation of the immune system and the production of certain metabolites.","oneSentence":"Oral capsule faecal microbiota transplantation involves the transfer of live microbes from a donor into the patient's gastrointestinal tract to restore a healthy balance of gut bacteria.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:24:36.440Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment-resistant Clostridioides difficile infection"},{"name":"Ulcerative colitis"},{"name":"Irritable bowel syndrome"}]},"trialDetails":[{"nctId":"NCT06623461","phase":"PHASE2","title":"LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2025-04-07","conditions":"Melanoma","enrollment":128},{"nctId":"NCT07496502","phase":"PHASE1, PHASE2","title":"Effect of Oral Microbiota on MDRO Decolonization","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2022-03-31","conditions":"Clostridioides Difficile Infection, Drug Resistance, Bacterial, Gastrointestinal Microbiome","enrollment":42},{"nctId":"NCT05669846","phase":"PHASE2","title":"Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC","status":"RECRUITING","sponsor":"Diwakar Davar","startDate":"2025-01-08","conditions":"Non Small Cell Lung Cancer","enrollment":26},{"nctId":"NCT07486492","phase":"EARLY_PHASE1","title":"Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2026-03-31","conditions":"Colorectal Cancer Metastatic, Fecal Microbiota Transplantation","enrollment":10},{"nctId":"NCT07477782","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05","conditions":"Primary Sclerosing Cholangitis (PSC), Inflammatory Bowel Disease (IBD)","enrollment":72},{"nctId":"NCT07463248","phase":"PHASE2","title":"PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Wang Xin","startDate":"2026-03-05","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":64},{"nctId":"NCT04373473","phase":"PHASE2","title":"Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-09-14","conditions":"Adults With Ulcerative Colitis","enrollment":58},{"nctId":"NCT07458984","phase":"PHASE3","title":"FMT Capsules for rCDI","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-02-25","conditions":"Clostridioides Difficile Infection Recurrence, FMT","enrollment":76},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT05740319","phase":"NA","title":"Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-06-10","conditions":"Irritable Bowel Syndrome","enrollment":102},{"nctId":"NCT03843385","phase":"PHASE3","title":"Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis","status":"RECRUITING","sponsor":"Andreas Stallmach","startDate":"2023-01-31","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":129},{"nctId":"NCT07401680","phase":"PHASE1","title":"Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population","status":"NOT_YET_RECRUITING","sponsor":"University of Alberta","startDate":"2026-03-01","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases, Clostridioides Difficile Infection","enrollment":85},{"nctId":"NCT07319364","phase":"PHASE1","title":"A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Fecal Microbiota Transplantation (FMT), Gastrointestinal Neoplasms, Antineoplastic Agents","enrollment":90},{"nctId":"NCT05598112","phase":"EARLY_PHASE1","title":"Effect of Gut Microbiome Intervention on Aging Via Oral FMT","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2023-04-24","conditions":"Aging, Frailty","enrollment":210},{"nctId":"NCT03420482","phase":"PHASE2","title":"Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2018-04-01","conditions":"Hepatic Encephalopathy","enrollment":30},{"nctId":"NCT05248191","phase":"PHASE1","title":"FMT for Postop Crohn's Disease","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2022-04-20","conditions":"Crohn Disease","enrollment":23},{"nctId":"NCT06218602","phase":"PHASE2","title":"Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-02-19","conditions":"Lymphoma","enrollment":40},{"nctId":"NCT06692361","phase":"NA","title":"Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder","status":"RECRUITING","sponsor":"Gang Wang","startDate":"2025-01-01","conditions":"Major Depressive Disorder (MDD), Depression - Major Depressive Disorder","enrollment":214},{"nctId":"NCT06481852","phase":"PHASE1","title":"A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-10-28","conditions":"Pulmonary Arterial Hypertension","enrollment":24},{"nctId":"NCT06030037","phase":"PHASE2","title":"Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma","status":"WITHDRAWN","sponsor":"Diwakar Davar","startDate":"2025-03-11","conditions":"PD-1 Refractory Advanced Melanoma","enrollment":""},{"nctId":"NCT05266807","phase":"PHASE3","title":"Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence","status":"RECRUITING","sponsor":"Benoit Guery","startDate":"2023-03-15","conditions":"Clostridioides Difficile Infection","enrollment":220},{"nctId":"NCT07154784","phase":"PHASE2, PHASE3","title":"Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis","status":"ENROLLING_BY_INVITATION","sponsor":"Seoul National University Hospital","startDate":"2023-07-19","conditions":"Ulcerative Colitis, Fecal Microbiota Transplantation","enrollment":30},{"nctId":"NCT05753774","phase":"NA","title":"Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders","status":"RECRUITING","sponsor":"Biao Zou","startDate":"2022-08-01","conditions":"Functional Gastrointestinal Disorders","enrollment":100},{"nctId":"NCT07094984","phase":"NA","title":"Comparison of Three Interventions for Antibiotic-Resistant Bacteria (ARB) Decolonization From the Gastrointestinal Tract","status":"RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2024-12-31","conditions":"Drug Resistance, Bacterial, Antimicrobial Drug Resistance","enrollment":360},{"nctId":"NCT07120490","phase":"NA","title":"STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-10","conditions":"Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, Fecal Microbiota Transplantation (FMT)","enrollment":424},{"nctId":"NCT04997733","phase":"PHASE3","title":"Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-09-22","conditions":"Crohn Disease","enrollment":150},{"nctId":"NCT05690048","phase":"PHASE2","title":"Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)","status":"RECRUITING","sponsor":"Michael Dill","startDate":"2025-07-16","conditions":"Immunotherapy, HCC - Hepatocellular Carcinoma","enrollment":48},{"nctId":"NCT06433180","phase":"PHASE3","title":"Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-07-01","conditions":"Irritable Bowel Syndrome","enrollment":150},{"nctId":"NCT07038226","phase":"NA","title":"Fecal Microbiota Transplantation Via Oral Capsule for Treating Refractory Constipation in Parkinson's Disease","status":"COMPLETED","sponsor":"Kyung Hee University Hospital","startDate":"2023-10-02","conditions":"Parkinson Disease, Constipation","enrollment":16},{"nctId":"NCT06346093","phase":"NA","title":"Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2024-04-02","conditions":"Advanced Gastric Cancer","enrollment":124},{"nctId":"NCT06687382","phase":"PHASE2","title":"Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis","status":"RECRUITING","sponsor":"Mikrobiomik Healthcare Company S.L.","startDate":"2025-04-03","conditions":"Diverticulitis, Diverticulitis of Sigmoid","enrollment":81},{"nctId":"NCT07003438","phase":"EARLY_PHASE1","title":"Study on the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Steroid - Dependent /Steroid-resistant Nephrotic Syndrome in Children","status":"NOT_YET_RECRUITING","sponsor":"Zhang Ting","startDate":"2025-06-01","conditions":"Steroid-Resistant Nephrotic Syndrome, Steroid-Dependent Nephrotic Syndrome","enrollment":120},{"nctId":"NCT03796598","phase":"PHASE1, PHASE2","title":"FMT in Cirrhosis and Hepatic Encephalopathy","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2019-07-29","conditions":"Cirrhosis, Hepatic Encephalopathy","enrollment":60},{"nctId":"NCT05202990","phase":"PHASE2","title":"Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-07-01","conditions":"Pediatric Ulcerative Colitis in Remission","enrollment":26},{"nctId":"NCT06931808","phase":"PHASE4","title":"Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"First Affiliated Hospital of Ningbo University","startDate":"2025-03-01","conditions":"Localized Advanced Rectal Adenocarcinoma","enrollment":20},{"nctId":"NCT06924645","phase":"NA","title":"Fecal Microbiota Transplantation for Preventing Gastrointestinal Symptoms in Extrapulmonary Neuroendocrine Neoplasms: A Real-World Study","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-05-01","conditions":"Treatment-related Gastrointestinal Toxicity (Including Diarrhea, Constipation, Nausea, and Vomiting), Extrapulmonary Neuroendocrine Neoplasms","enrollment":40},{"nctId":"NCT06388863","phase":"NA","title":"Evaluation of the Efficacy and Safety of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-02-21","conditions":"Parkinson Disease","enrollment":76},{"nctId":"NCT05201079","phase":"PHASE3","title":"Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin","status":"COMPLETED","sponsor":"Mikrobiomik Healthcare Company S.L.","startDate":"2021-10-29","conditions":"Recurrent Clostridium Difficile Infection, Primary Clostridium Difficile Infection","enrollment":93},{"nctId":"NCT06776029","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Radiation-Induced Proctopathy","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-02-01","conditions":"Radiation Induced Proctitis","enrollment":20},{"nctId":"NCT05006430","phase":"PHASE1, PHASE2","title":"Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis","status":"RECRUITING","sponsor":"Prasun Kumar Jalal","startDate":"2023-01-21","conditions":"Alcoholic Hepatitis","enrollment":50},{"nctId":"NCT06393400","phase":"PHASE1","title":"CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)","status":"RECRUITING","sponsor":"John Lenehan","startDate":"2025-01-08","conditions":"Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma","enrollment":20},{"nctId":"NCT03617445","phase":"PHASE2","title":"Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2022-08-03","conditions":"Clostridium Difficile Infection Recurrence","enrollment":3},{"nctId":"NCT04269850","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD","status":"TERMINATED","sponsor":"St. Petersburg State Pavlov Medical University","startDate":"2019-09-01","conditions":"Intestinal GVHD","enrollment":2},{"nctId":"NCT06593366","phase":"NA","title":"Fecal Microbiota Transplant for Anorexia Nervosa","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2025-01-01","conditions":"Anorexia Nervosa Restricting Type, Anorexia Nervosa, Anorexia in Adolescence","enrollment":20},{"nctId":"NCT06669936","phase":"","title":"Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection","status":"COMPLETED","sponsor":"Alexander Khoruts","startDate":"2018-05-01","conditions":"Recurrent C. Difficile Infection","enrollment":24},{"nctId":"NCT06643533","phase":"","title":"Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)","status":"NOT_YET_RECRUITING","sponsor":"Fujian Provincial Hospital","startDate":"2025-01-01","conditions":"Hepatocellular Carcinoma Non-resectable","enrollment":15},{"nctId":"NCT05821010","phase":"PHASE2","title":"Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2023-03-17","conditions":"Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation","enrollment":48},{"nctId":"NCT05790356","phase":"NA","title":"Fecal Microbial Transplantation for Rheumatoid Arthritis Trial","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2023-08-01","conditions":"Arthritis, Arthritis, Rheumatoid, Fecal Microbiota Transplantation","enrollment":30},{"nctId":"NCT06297421","phase":"PHASE2","title":"Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Hospital of Southern Medical University","startDate":"2024-09","conditions":"Irritable Bowel Syndrome With Diarrhea, Fecal Microbiota Transplantation, Mental Health Issue","enrollment":88},{"nctId":"NCT06205862","phase":"PHASE2","title":"Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA)","status":"RECRUITING","sponsor":"Shenzhen Hospital of Southern Medical University","startDate":"2024-04-09","conditions":"Fecal Microbiota Transplantation, Colorectal Adenoma, Gastrointestinal Microbiome","enrollment":466},{"nctId":"NCT04760665","phase":"PHASE2","title":"Clinical Trial to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Carbapenemase-producing Klebsiella Pneumoniae","status":"TERMINATED","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2021-10-04","conditions":"Carbapenemase-producing Enterobacteriaceae Infection","enrollment":2},{"nctId":"NCT06419530","phase":"NA","title":"A Study on Probiotic Formula in Autistic Children","status":"NOT_YET_RECRUITING","sponsor":"Third Military Medical University","startDate":"2024-06","conditions":"Autism Spectrum Disorder","enrollment":156},{"nctId":"NCT03678493","phase":"PHASE2","title":"A Study of FMT in Patients With AML Allo HSCT in Recipients","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2019-09-09","conditions":"Acute Myeloid Leukemia, Allogeneic Hematopoietic Cell Transplantation","enrollment":100},{"nctId":"NCT05786404","phase":"PHASE1","title":"Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-12-15","conditions":"Active Ulcerative Colitis (UC)","enrollment":20},{"nctId":"NCT06368895","phase":"PHASE1","title":"Fecal Microbiota Transplantation by Oral Capsules for Hepatic Encephalopathy Treatment","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-04-07","conditions":"Hepatic Encephalopathy, Dysbiosis","enrollment":60},{"nctId":"NCT05654753","phase":"PHASE2, PHASE3","title":"The Efficacy of Fecal Microbiota Transplatation on Axial Spondyloarthritis Patients Resistant to Conventional Treatment","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-03-28","conditions":"Axial Spondyloarthritis","enrollment":20},{"nctId":"NCT04968951","phase":"EARLY_PHASE1","title":"Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)","status":"TERMINATED","sponsor":"Ari M Grinspan","startDate":"2021-11-10","conditions":"Ulcerative Colitis, FMT, Fecal Microbiota Transplant","enrollment":4},{"nctId":"NCT06250413","phase":"NA","title":"Autoflor -Lyophilized Capsulated Autological FMT to Restore Gut Microbiome After Treatment With Antibiotics","status":"NOT_YET_RECRUITING","sponsor":"Otto Helve","startDate":"2024-02","conditions":"Microbial Colonization, Antibiotic Side Effect","enrollment":40},{"nctId":"NCT05873348","phase":"NA","title":"A Controlled Study on Regulation of Systemic Inflammation by Fecal Bacteria Transplantation in Patients With COVID-19.","status":"COMPLETED","sponsor":"Shanghai 10th People's Hospital","startDate":"2023-01-10","conditions":"Fecal Microbiota Transplantation, COVID-19 Infection","enrollment":30},{"nctId":"NCT04805879","phase":"PHASE2, PHASE3","title":"The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2021-03-04","conditions":"Depression, Treatment Resistant Depression","enrollment":80},{"nctId":"NCT05622526","phase":"PHASE2","title":"Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis","status":"UNKNOWN","sponsor":"Instituto de Investigación Marqués de Valdecilla","startDate":"2024-01-01","conditions":"Patients With Nonalcoholic Steatohepatitis","enrollment":96},{"nctId":"NCT03970200","phase":"PHASE2","title":"Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2020-01-16","conditions":"Severe Clostridium Difficile Infection, Severe-Complicated/Fulminant Clostridium Difficile Infection","enrollment":15},{"nctId":"NCT03378167","phase":"PHASE1","title":"PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial","status":"COMPLETED","sponsor":"McMaster Children's Hospital","startDate":"2018-12-01","conditions":"Crohn Disease, Pediatric Crohns Disease, Inflammatory Bowel Diseases","enrollment":17},{"nctId":"NCT05502913","phase":"PHASE2","title":"Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer","status":"RECRUITING","sponsor":"Soroka University Medical Center","startDate":"2023-09-01","conditions":"Metastatic Lung Cancer","enrollment":80},{"nctId":"NCT04280471","phase":"PHASE1","title":"Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease","status":"WITHDRAWN","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2023-09-01","conditions":"Acute Graft Versus Host Disease, Gastrointestinal Tract Acute Graft Versus Host Disease, Severe Gastrointestinal Tract Acute Graft Versus Host Disease","enrollment":""},{"nctId":"NCT04202211","phase":"PHASE2","title":"FMT for Remission of Active Ulcerative Colitis in Adults","status":"WITHDRAWN","sponsor":"University of British Columbia","startDate":"2022-03","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":""},{"nctId":"NCT05608447","phase":"PHASE1","title":"Effect of Intensive FMT on Primary Hypertension","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2023-01-01","conditions":"Hypertension","enrollment":72},{"nctId":"NCT03110133","phase":"PHASE2","title":"Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff","status":"COMPLETED","sponsor":"Finch Research and Development LLC.","startDate":"2017-05-08","conditions":"Clostridium Difficile Infection Recurrence","enrollment":206},{"nctId":"NCT03078803","phase":"PHASE2","title":"Fecal Transplant for Crohn's Disease","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2017-03-28","conditions":"Crohn Disease","enrollment":38},{"nctId":"NCT05076656","phase":"EARLY_PHASE1","title":"Epigenetic and Microbiota Modifications","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2019-06-10","conditions":"Diabetes type2, Obesity","enrollment":22},{"nctId":"NCT05461833","phase":"NA","title":"FMT for Post-infectious IBS","status":"COMPLETED","sponsor":"Bogomolets National Medical University","startDate":"2020-09-01","conditions":"Irritable Bowel Syndrome","enrollment":59},{"nctId":"NCT05427331","phase":"NA","title":"FMT Capsules in Treatment of Patients With Insomnia Clinical Research","status":"UNKNOWN","sponsor":"Third Military Medical University","startDate":"2022-06-20","conditions":"Chronic Insomnia","enrollment":60},{"nctId":"NCT03795233","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplant for Primary CDI","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2019-08-23","conditions":"Clostridium Difficile Infection","enrollment":5},{"nctId":"NCT03720392","phase":"PHASE2","title":"Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)","status":"TERMINATED","sponsor":"Zachariah Michael DeFilipp","startDate":"2019-01-15","conditions":"Allogeneic Hematopoietic Cell Transplantation (HCT)","enrollment":8},{"nctId":"NCT05001360","phase":"NA","title":"Study of FMT Combined With Nivolumab in Gastric Cancer","status":"WITHDRAWN","sponsor":"Fujian Cancer Hospital","startDate":"2021-10","conditions":"Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma, Esophagus Adenocarcinoma","enrollment":""},{"nctId":"NCT02960074","phase":"PHASE1","title":"Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients","status":"COMPLETED","sponsor":"Rima Rachid","startDate":"2017-03-03","conditions":"Peanut Allergy","enrollment":15},{"nctId":"NCT04406129","phase":"EARLY_PHASE1","title":"Effect of Gut Microbiome Restoration on Primary Hypertension Via FMT","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2021-03-17","conditions":"Hypertension","enrollment":120},{"nctId":"NCT03152188","phase":"PHASE1","title":"Oral Fecal Transplant in Cirrhosis","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2017-06-12","conditions":"Hepatic Encephalopathy, Cirrhosis, Liver","enrollment":20},{"nctId":"NCT04890405","phase":"NA","title":"Clinical Study of Selective Fecal Microbiota Transplantation in the Treatment of Irritable Bowel Syndrome.","status":"UNKNOWN","sponsor":"Yanling Wei","startDate":"2021-05-20","conditions":"Irritable Bowel Syndrome Variant of Childhood","enrollment":70},{"nctId":"NCT03006809","phase":"PHASE1","title":"Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis","status":"COMPLETED","sponsor":"Najwa Elnachef","startDate":"2017-03-02","conditions":"Ulcerative Colitis","enrollment":30},{"nctId":"NCT04824222","phase":"PHASE3","title":"The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2021-04","conditions":"Covid19","enrollment":366},{"nctId":"NCT03621657","phase":"PHASE2","title":"The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2019-03-21","conditions":"Clostridium Difficile Infection, C.Difficile Diarrhea, CDI","enrollment":1},{"nctId":"NCT03643887","phase":"PHASE2","title":"Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients","status":"WITHDRAWN","sponsor":"University of Wisconsin, Madison","startDate":"2022-09-01","conditions":"Clostridium Difficile Infection","enrollment":""},{"nctId":"NCT04431934","phase":"NA","title":"Efficacy of a Probiotic or Fecal Microbiota Transplantation (FMT) on the Eradication of Rectal Multidrug-resistant Gram-negative Bacilli (MDR-GNB) Carriage (PROFTMDECOL)","status":"UNKNOWN","sponsor":"Hospital Clinic of Barcelona","startDate":"2020-11-16","conditions":"CARRIER STATE","enrollment":437},{"nctId":"NCT04746222","phase":"PHASE2, PHASE3","title":"Oral Capsule Faecal Microbiota Transplantation for CPE Decolonization","status":"UNKNOWN","sponsor":"Tan Tock Seng Hospital","startDate":"2021-07","conditions":"Carbapenem-Resistant Enterobacteriaceae Infection","enrollment":108},{"nctId":"NCT04622475","phase":"NA","title":"Efficacy and Safety of FMT Capsule Treating Steroid-refractory GI-aGvHD","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2020-11","conditions":"Steroid-refractory Gastrointestinal Acute Graft Versus Host Disease","enrollment":10},{"nctId":"NCT03998423","phase":"PHASE1","title":"Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2019-11-14","conditions":"Alzheimer Disease","enrollment":5},{"nctId":"NCT03329560","phase":"PHASE1","title":"Safety of FMT Using Oral Encapsulated PRIM-DJ2727 in HIV","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-12","conditions":"HIV-1-infection","enrollment":6},{"nctId":"NCT04361097","phase":"NA","title":"Fecal Microbiota Transplantation as a Therapeutic Strategy in the Progression of Chronic Kidney Disease","status":"COMPLETED","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2018-08-07","conditions":"Chronic Kidney Disease Due to Hypertension, Chronic Kidney Disease Due to Type 2 Diabetes Mellitus","enrollment":28},{"nctId":"NCT04165200","phase":"NA","title":"Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV","status":"COMPLETED","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2018-09-06","conditions":"HIV Infections","enrollment":22},{"nctId":"NCT03281044","phase":"PHASE2","title":"Fecal Microbiota Transplantation in Depression","status":"TERMINATED","sponsor":"Psychiatric Hospital of the University of Basel","startDate":"2018-10-24","conditions":"Major Depressive Disorder","enrollment":4},{"nctId":"NCT03063437","phase":"PHASE2","title":"A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization","status":"COMPLETED","sponsor":"Microbiome Health Research Institute","startDate":"2017-08-17","conditions":"Antibiotic Resistant Strain","enrollment":9},{"nctId":"NCT03391674","phase":"NA","title":"Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization","status":"WITHDRAWN","sponsor":"Rambam Health Care Campus","startDate":"2019-01","conditions":"Antibiotic Resistant Strain, Microbial Colonization","enrollment":""},{"nctId":"NCT02741518","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplantation for the Treatment of Obesity","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2017-04-01","conditions":"Obesity","enrollment":22},{"nctId":"NCT02254811","phase":"PHASE2, PHASE3","title":"FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2014-09-18","conditions":"Enterocolitis Clostridium Difficile Recurrent","enrollment":116},{"nctId":"NCT03527056","phase":"EARLY_PHASE1","title":"Pilot Study Using Oral Capsule FMT to Decolonize GI CRE","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2019-06","conditions":"Enterobacteriaceae Infections, Fecal Microbiota Transplantation","enrollment":""},{"nctId":"NCT04034758","phase":"NA","title":"Safety and Efficacy of Heterologous FMT by SQIMC-md Capsule in Mild-moderate Ulcerative Colitis Patients","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2019-08-30","conditions":"Ulcerative Colitis","enrollment":99},{"nctId":"NCT02328547","phase":"PHASE2","title":"Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2015-05","conditions":"Irritable Bowel Syndrome","enrollment":48},{"nctId":"NCT02782325","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-06-01","conditions":"Pouchitis","enrollment":6},{"nctId":"NCT03804736","phase":"NA","title":"Fecal Microbiota Transplant by Oral Capsules With Lactobacilli for Recurrent Clostridium Difficile Infection","status":"UNKNOWN","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2016-11-01","conditions":"Clostridium Difficile Infection","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["capsule FMT","FMT"],"phase":"phase_3","status":"active","brandName":"Oral capsule faecal microbiota transplantation","genericName":"Oral capsule faecal microbiota transplantation","companyName":"Tan Tock Seng Hospital","companyId":"tan-tock-seng-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"Oral capsule faecal microbiota transplantation involves the transfer of live microbes from a donor into the patient's gastrointestinal tract to restore a healthy balance of gut bacteria. Used for Treatment-resistant Clostridioides difficile infection, Ulcerative colitis, Irritable bowel syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}